Health Care • Hospital/Nursing Management
$2.41 ▼ -0.25
(-9.40%)
MKT CAP: $339.8M • VOL: 8.04M
52W L $2 52W H $4
CYH // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $12.48B | $12.63B | $12.49B |
| YoY Revenue Growth % | -1.2% | +1.2% | — |
| Gross Profit | $10.62B | $10.69B | — |
| Gross Margin % | 85.1% | 84.6% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $1.49B | $542.0M | $957.0M |
| Operating Margin % | 11.9% | 4.3% | 7.7% |
| Net Income (GAAP) | $509.0M | -$516.0M | -$133.0M |
| EBITDA (Normalized) | $1.76B | $830.0M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $543.0M | $480.0M | $210.0M |
| Capital Expenditures (CapEx) | $335.0M | $360.0M | — |
| Free Cash Flow (FCF) | $208.0M | $120.0M | $210.0M |
| FCF Margin % | 1.7% | 0.9% | 1.7% |
| Return on Invested Capital (ROIC %) | 13.5% | 4.5% | — |
| Cash & Short-Term Equivalents | $260.0M | $37.0M | — |
| Total Debt (Short + Long Term) | $10.38B | $11.43B | — |
| Total Stockholders' Equity | -$1.39B | -$1.91B | — |
NO QUARTERLY 10-Q XBRL STATEMENTS AVAILABLE IN CURRENT CACHE FOR CYH.